{"id":"https://openalex.org/W3131880140","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-09-06","title":"Abstract OT-09-06: Phase II neoadjuvant study of GDC-9545 + palbociclib (palbo) vs anastrozole (A) + palbo in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2- eBC)","display_name":"Abstract OT-09-06: Phase II neoadjuvant study of GDC-9545 + palbociclib (palbo) vs anastrozole (A) + palbo in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2- eBC)","publication_year":2021,"publication_date":"2021-02-15","ids":{"openalex":"https://openalex.org/W3131880140","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-09-06","mag":"3131880140"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs20-ot-09-06","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-09-06","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ot-09-06","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068059897","display_name":"Sara Alsterlind Hurvitz","orcid":"https://orcid.org/0000-0001-7808-7191","observed_orcids":["https://orcid.org/0000-0001-7808-7191"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4390039293","display_name":"UCLA Jonsson Comprehensive Cancer Center","ror":"https://ror.org/0599cs764","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4390039293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara A Hurvitz","raw_affiliation_strings":["1University of California, Los Angeles/Jonsson Comprehensive Cancer Center (UCLA/JCCC), Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, Los Angeles/Jonsson Comprehensive Cancer Center (UCLA/JCCC), Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4390039293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017728105","display_name":"Peter Andreas Fasching","orcid":"https://orcid.org/0000-0003-4885-8471","observed_orcids":["https://orcid.org/0000-0003-4885-8471","https://orcid.org/0000-0003-1709-1079"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]},{"id":"https://openalex.org/I4210149747","display_name":"Comprehensive Cancer Center Erlangen","ror":"https://ror.org/05jfz9645","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210149747"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter A Fasching","raw_affiliation_strings":["2University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center (CCC) Erlangen-EMN, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center (CCC) Erlangen-EMN, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053","https://openalex.org/I4210149747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101445353","display_name":"Yeon Hee Park","orcid":"https://orcid.org/0000-0003-4156-9212","observed_orcids":["https://orcid.org/0000-0003-4156-9212"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Yeon Hee Park","raw_affiliation_strings":["3Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea, Republic of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea, Republic of","institution_ids":["https://openalex.org/I2802194831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088121773","display_name":"Vanesa Quiroga","orcid":"https://orcid.org/0000-0002-7852-474X","observed_orcids":["https://orcid.org/0000-0002-7852-474X"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vanesa Quiroga","raw_affiliation_strings":["4Institut Catal\u00e0 d'Oncologia, Barcelona, Spain, and GEICAM Spanish Breast Cancer Group, San Sebasti\u00e1n de los Reyes, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut Catal\u00e0 d'Oncologia, Barcelona, Spain, and GEICAM Spanish Breast Cancer Group, San Sebasti\u00e1n de los Reyes, Madrid, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083418555","display_name":"Tanja Badovinac \u010crnjevi\u0107","orcid":"https://orcid.org/0000-0002-0922-3409","observed_orcids":["https://orcid.org/0000-0002-0922-3409"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Tanja Badovinac Crnjevic","raw_affiliation_strings":["5PDO \u2013 Clinical Science Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5PDO \u2013 Clinical Science Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054850677","display_name":"Rodrigo Fresco","orcid":"https://orcid.org/0000-0001-5342-3486","observed_orcids":["https://orcid.org/0000-0001-5342-3486"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rodrigo Fresco","raw_affiliation_strings":["6Translational Research in Oncology, Montevideo, Uruguay"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Translational Research in Oncology, Montevideo, Uruguay","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021613406","display_name":"Vanesa L\u00f3pez-Valverde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Vanesa L\u00f3pez-Valverde","raw_affiliation_strings":["5PDO \u2013 Clinical Science Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5PDO \u2013 Clinical Science Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069835344","display_name":"Jutta Steinseifer","orcid":"https://orcid.org/0000-0002-1358-6245","observed_orcids":["https://orcid.org/0000-0002-1358-6245"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jutta Steinseifer","raw_affiliation_strings":["5PDO \u2013 Clinical Science Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5PDO \u2013 Clinical Science Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052597823","display_name":"Chenglin Ye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chenglin Ye","raw_affiliation_strings":["7Oncology Biostatistics, Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Oncology Biostatistics, Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["8Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"4_Supplement","first_page":"OT","last_page":"09"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9739999771118164},{"id":"https://openalex.org/keywords/anastrozole","display_name":"anastrozole","score":0.9779999852180481},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.9160000085830688},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8289999961853027},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8830000162124634},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.7889999747276306},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.9629999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7630766034126282},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.5840309262275696},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5620654821395874},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.5569884181022644},{"id":"https://openalex.org/C2776215463","wikidata":"https://www.wikidata.org/wiki/Q419143","display_name":"Anastrozole","level":5,"score":0.5412800312042236},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5398015975952148},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5308165550231934},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.43944215774536133},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4310969114303589},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4150611460208893},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.41251489520072937},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.37084734439849854},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.18325892090797424}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs20-ot-09-06","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-09-06","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ot-09-06","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282028151","https://openalex.org/W3201907175","https://openalex.org/W3032278072","https://openalex.org/W4221119482","https://openalex.org/W4251387620","https://openalex.org/W4220914684","https://openalex.org/W4295816936","https://openalex.org/W4322775120","https://openalex.org/W2400955312","https://openalex.org/W4221105522"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Endocrine":[2],"therapies":[3],"(ETs)":[4],"are":[5,32,226,398,433],"the":[6,36,40,72,241,301,392,427,463,575,655],"mainstay":[7],"of":[8,56,61,74,191,198,311,322,410,628,654],"ER+":[9,53,112],"BC":[10,123],"management;":[11],"however,":[12],"many":[13],"patients":[14,411,569],"(pts)":[15],"have":[16,82,124],"disease":[17,346],"relapse":[18],"or":[19,105,231,325,454,586,593],"develop":[20],"therapeutic":[21],"resistance.":[22],"CDK4/6":[23,109],"and":[24,31,65,141,165,240,288,368,402,442,457,467,470,495,508,529],"aromatase":[25],"inhibitors":[26,110],"decrease":[27],"Ki67":[28,44,69,369,383,415,436,488,502],"expression":[29],"significantly":[30],"potent":[33],"in":[34,39,52,106,118,159,166,195,211,291,355,426,435,462,510,522,541,638],"arresting":[35],"cell":[37,62,404],"cycle":[38,63,405],"neoadjuvant":[41,67,189,213,242,302,428,464,626],"eBC":[42,221],"setting.":[43],"is":[45,135,274,293,380,479,567,577],"a":[46,103,139,183,196,212,589],"proliferation":[47],"biomarker":[48],"with":[49,108,121,142,144,154,161,168,218,277,335,412,552,641],"prognostic":[50],"value":[51],"BC.":[54,113],"Efficacy":[55],"ETs":[57,75],"relies":[58],"on":[59,319],"induction":[60],"arrest,":[64],"during":[66,391],"treatment,":[68],"scores":[70,416,437,503,555],"reflect":[71],"ability":[73],"to":[76,229,388,440,446,587],"suppress":[77],"proliferation.":[78],"Selective":[79],"ER":[80,95],"degraders":[81],"also":[83,473],"shown":[84,125],"efficacy":[85,292,378,396,431],"against":[86],"these":[87],"tumors.":[88],"The":[89,233,376],"highly":[90],"potent,":[91],"non-steroidal,":[92],"oral":[93,127],"selective":[94],"degrader":[96],"GDC-9545":[97,134,192,204,230,252,269,312,629],"has":[98],"therefore":[99],"been":[100],"developed":[101],"as":[102,138,272],"monotherapy":[104,140],"combination":[107],"for":[111,215,526,579],"Preliminary":[114],"phase":[115,184,235],"Ib":[116],"data":[117],"postmenopausal":[119,216,639],"women":[120,217,640],"metastatic":[122],"that":[126],"100":[128],"mg":[129,258,264,268,316],"once":[130,574],"daily":[131],"(PO":[132],"QD)":[133],"well":[136,275],"tolerated":[137,276],"palbo,":[143],"encouraging":[145],"antitumor":[146],"activity":[147,280],"(clinical":[148],"benefit":[149,157],"rates:":[150],"55%":[151],"without":[152],"palbo/81%":[153],"palbo;":[155],"clinical":[156],"observed":[158],"pts":[160,167,304,331],"prior":[162],"fulvestrant":[163],"treatment":[164,422,451],"detectable":[169],"ESR1":[170],"mutations":[171],"at":[172,256,262,295,362,423,452,516,556,570],"enrollment)":[173],"(Lim":[174],"et":[175,282],"al.":[176,283],"ASCO":[177],"2020;":[178],"abstract":[179,286],"1023).":[180],"We":[181],"present":[182],"II,":[185],"randomized,":[186],"open-label,":[187],"two-arm,":[188],"study":[190,576,627],"vs":[193,207,485,492,500,633],"A":[194,208,326,601,604],"window":[197],"opportunity":[199],"(WoO)":[200],"phase,":[201,214,243,303],"followed":[202],"by":[203,481,537],"+":[205,209,313,327,630,636],"palbo":[206,210,314,637],"ER+/HER2-":[219],"untreated":[220,645],"(NCT04436744).":[222],"Trial":[223],"design":[224],"Pts":[225],"randomized":[227],"1:1":[228],"A.":[232],"WoO":[234,393],"will":[236,253,305,472,504,519,534,546,561],"last":[237],"14":[238],"days;":[239],"16":[244],"weeks":[245],"(4":[246],"x":[247,308],"28-day":[248,309],"cycles)":[249],"before":[250],"surgery.":[251],"be":[254,474,505,520,535,547,562],"given":[255],"30":[257,267,298],"PO":[259,265,317],"QD;":[260],"A,":[261],"1":[263],"QD.":[266],"was":[270],"selected":[271],"it":[273],"promising":[278],"anti-tumor":[279],"(Jhaveri":[281],"SABCS":[284],"2019;":[285],"PD7-05),":[287],"no":[289],"improvement":[290],"expected":[294],"doses":[296],">":[297],"mg.":[299],"During":[300],"receive":[306],"4":[307],"cycles":[310],"(125":[315],"QD":[318],"days":[320],"1-21":[321],"each":[323,527],"cycle)":[324],"palbo.":[328],"Eligibility":[329],"Female":[330],"\u2265":[332,352,371,493],"18":[333],"years":[334],"ECOG":[336],"performance":[337],"status":[338,483,498],"0-1,":[339],"histologically":[340],"confirmed":[341],"invasive":[342],"breast":[343,647],"carcinoma,":[344],"measurable":[345],"(modified":[347],"RECIST":[348],"v1.1),":[349],"primary":[350,377],"tumor":[351],"1.5":[353,366],"cm":[354],"its":[356],"longest":[357],"diameter":[358],"(tumor":[359],"size":[360],"category":[361],"presentation:":[363],"cT1c":[364],"[\u2265":[365],"cm]-cT4a-c),":[367],"score":[370,384,489,543],"5%":[372],"stained":[373,419],"nuclei.":[374],"Aims":[375],"endpoint":[379],"mean":[381,542],"relative":[382,514],"change":[385,515],"from":[386,438,443],"baseline":[387,439,557],"week":[389,424,444,517,559],"2":[390,445,518,560],"phase.":[394,429,465],"Secondary":[395],"endpoints":[397,432],"objective":[399],"response":[400,460],"rate":[401,408,449,461],"complete":[403,459],"arrest":[406],"(CCCA)":[407],"(proportion":[409],"centrally":[413,506],"assessed":[414,507],"\u2264":[417],"2.7%":[418],"nuclei":[420],"upon":[421],"2)":[425],"Exploratory":[430],"changes":[434],"surgery":[441,453],"surgery,":[447],"CCCA":[448],"(upon":[450],"post-treatment":[455],"biopsy),":[456],"pathologic":[458],"Safety":[466],"tolerability,":[468],"pharmacokinetics,":[469],"biomarkers":[471],"assessed.":[475],"Statistical":[476],"methods":[477],"Randomization":[478],"stratified":[480],"T":[482],"(cT1c-cT2":[484],"cT3-cT4":[486],"a-c),":[487],"(<":[490],"20%":[491],"20%),":[494],"progesterone":[496],"receptor":[497],"(positive":[499],"negative).":[501],"measured":[509],"percentage":[511,524],"scores.":[512],"Mean":[513],"summarized":[521],"original":[523],"scales":[525],"arm,":[528],"corresponding":[530],"95%":[531],"confidence":[532],"intervals":[533],"calculated":[536],"normal":[538],"approximation.":[539],"Change":[540],"between":[544],"arms":[545],"compared":[548],"via":[549],"z-test.":[550],"Patients":[551],"missing":[553],"central":[554],"and/or":[558],"excluded.":[563],"Accrual":[564],"Target":[565],"enrollment":[566],"215":[568],"~90":[571],"sites":[572],"globally":[573],"open":[578],"enrollment.":[580],"Contact":[581],"information":[582,585],"For":[583],"more":[584],"refer":[588],"patient,":[590],"email":[591],"global.rochegenentechtrials@roche.com":[592],"call":[594],"1-888-662-6728":[595],"(USA":[596],"only).":[597],"Citation":[598],"Format:":[599],"Sara":[600],"Hurvitz,":[602],"Peter":[603],"Fasching,":[605],"Yeon":[606],"Hee":[607],"Park,":[608],"Vanesa":[609,616],"Quiroga,":[610],"Tanja":[611],"Badovinac":[612],"Crnjevic,":[613],"Rodrigo":[614],"Fresco,":[615],"L\u00f3pez-Valverde,":[617],"Jutta":[618],"Steinseifer,":[619],"Chenglin":[620],"Ye,":[621],"Aditya":[622],"Bardia.":[623],"Phase":[624],"II":[625],"palbociclib":[631],"(palbo)":[632],"anastrozole":[634],"(A)":[635],"estrogen":[642],"receptor-positive,":[643],"HER2-negative,":[644],"early":[646],"cancer":[648],"(ER+/HER2-":[649],"eBC)":[650],"[abstract].":[651],"In:":[652],"Proceedings":[653],"2020":[656,663],"San":[657,666],"Antonio":[658],"Breast":[659],"Cancer":[660,672],"Virtual":[661],"Symposium;":[662],"Dec":[664],"8-11;":[665],"Antonio,":[667],"TX.":[668],"Philadelphia":[669],"(PA):":[670],"AACR;":[671],"Res":[673],"2021;81(4":[674],"Suppl):Abstract":[675],"nr":[676],"OT-09-06.":[677]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2021-03-01T00:00:00"}